Background The WHO Director-General has issued a call for action to eliminate cervical
cancer as a public health problem. To help inform global efforts, we modelled potential human …

Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Background Modelling studies have been widely used to inform human papillomavirus (HPV)
vaccination policy decisions; however, many models exist and it is not known whether they …

Importance Evidence on the relative benefits and harms of primary high-risk human
papillomavirus (hrHPV) testing is needed to inform guidelines. Objective To inform the US …

Background Increasingly, countries have introduced female vaccination against human
papillomavirus (HPV), causally linked to several cancers and genital warts, but few have …

Mathematical models of cervical cancer have been widely used to evaluate the comparative
effectiveness and cost-effectiveness of preventive strategies. Major advances in the …

Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Background: Current US cervical cancer screening guidelines do not differentiate recommendations
based on a woman’s human papillomavirus (HPV) vaccination status. Changes to …

Background In May, 2018, the Director-General of WHO issued a global call to eliminate
cervical cancer as a public health problem, which will involve ambitious screening and …

Background: Studies suggest that cervical cancer screening practice in the United States is
inefficient. The cost and health implications of nonadherence in the screening process …